Completeness of reporting and case ascertainment for neonatal tetanus in rural Pakistan

International Journal of Infectious Diseases

Volumn 15, Issue 8, 2011, Pages

  Lambo, Jonathan A ^a   Khahro, Zahid H ^b   Memon, Mahmood I ^c   Lashari, Muhammad I ^d  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Contech International ^*  (Pakistan)

^d CIVIL HOSPITAL   (Pakistan)

Author keywords

Completeness; Dadu District; Disease notification; Incidence; Neonatal tetanus; Surveillance

Indexed keywords

ARTICLE; CASE MANAGEMENT; CONTROLLED STUDY; DISEASE REGISTRY; DISEASE SURVEILLANCE; FEMALE; HEALTH PROMOTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEASLES; MEDICAL RECORD REVIEW; NEWBORN; NEWBORN TETANUS; ORGANIZATION AND MANAGEMENT; OUTPATIENT CARE; PAKISTAN; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; RURAL AREA; VOLUNTARY REPORTING;

FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; PAKISTAN; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RURAL POPULATION; TETANUS; TETANUS TOXOID; VACCINATION;

EID: 79961030273     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.04.011     Document Type: Article

References (25)

1. Expanded Programme on Immunization The use of survey data to supplement disease surveillance. Wkly Epidemiol Rec 1982, 57:361-362.
2. World Health Organization Progress towards the global elimination of neonatal tetanus, 1990-1998. Wkly Epidemiol Rec 1999, 74:73-80.
3. Expanded Programme on Immunization Global Advisory Group. Part II: achieving the major disease control goals. Wkly Epidemiol Rec 1994, 69:31-35.
4. Stanfield J.P., Galazka A. Neonatal tetanus in the world today. Bull World Health Organ 1984, 62:647-669.
5. Whitman C., Belgharbi M., Gasse F., Torel C., Mattei V., Zoffmann H. Progress towards the global elimination of neonatal tetanus. World Health Stat Q 1992, 45:248-256.
6. Singh J., Datta K.K., Foster S.O. Sensitivity of neonatal tetanus surveillance system in India. Indian Pediatrics 1997, 34:398-401.
7. World Health Organization. WHO vaccine-preventable diseases monitoring system 2009 global summary. WHO/IVB/2009. Geneva: WHO; 2009. Available at: (accessed August 2010). http://whqlibdoc.who.int/hq/2009/WHO_IVB_2009_eng.pdf.
8. Expanded Programme on Immunization Validation of neonatal tetanus elimination in the Congo by a lot quality-assurance cluster sample survey. Wkly Epidemiol Rec 2009, 84:470-476.
9. Vandelaer J., Birmingham M., Gasse F., Kurian M., Shaw C., Garnier S. Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine 2003, 21:3442-3445.
10. World Health Organization Acute flaccid paralysis surveillance: a global platform for detecting and responding to priority infectious diseases. Wkly Epidemiol Rec 2004, 79:425-432.
11. Centers for Disease Control Prevention Acute flaccid paralysis surveillance systems for expansion to other diseases. MMWR Morb Mortal Wkly Rep 2004, 53:1113-1116.
12. World Health Organization, Department of Vaccines and Biologicals. Report of a WHO meeting on monitoring and assessment of vaccine-preventable diseases, Cairo, Egypt, 21-23 January 2001. WHO/V&B/02.03. Geneva: WHO; 2002, p. 28-30.
13. World Health Organization. Progress towards global MNT elimination. Available at: (accessed March 2011). http://www.who.int/immunization_monitoring/diseases/MNTE_initiative/en/index4.html.
14. World Health Organization. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. WHO/V & B/03.01. Geneva: WHO; 2003. Available at: (accessed August 2010). http://www.who.int/vaccines-documents/DocsPDF06/843.pdf.
15. Whitfield K., Kelly H. Using the two-source capture-recapture method to estimate the incidence of acute flaccid paralysis in Victoria, Australia. Bull World Health Organ 2002, 80:846-851.
16. John T.J., Samuel R., Balraj V., John R. Disease surveillance at district level: a model for developing countries. Lancet 1998, 352:58-61.
17. Oum S., Chandramohan D., Cairncross S. Community-based surveillance: a pilot study from rural Cambodia. Trop Med Int Health 2005, 10:689-697.
18. World Health Organization. Field manual for neonatal tetanus elimination. WHO/V & B/99.14. Geneva: WHO; 1999. Available at: (accessed August 2010). http://whqlibdoc.who.int/hq/1999/WHO_V%26B_99.14.pdf.
19. Doyle T.J., Glynn M.K., Groseclose S.L. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. Am J Epidemiol 2002, 155:866-874.
20. Chai F., Prevots D.R., Wang X., Birmingham M., Zhang R. Neonatal tetanus incidence in China, 1996-2001, and risk factors for neonatal tetanus, Guangxi Province, China. Int J Epidemiol 2004, 33:551-557.
21. Suleman O. Mortality from tetanus neonatorum in Punjab (Pakistan). Pak Pediatr J 1982, 6:152-183.
22. Quddus A., Luby S., Rahbar M., Pervaiz Y. Neonatal tetanus: mortality rate and risk factors in Loralai district, Pakistan. Int J Epidemiol 2002, 31:648-653.
23. Brenner H. Use and limitations of the capture-recapture method in disease monitoring with two dependent sources. Epidemiology 1994, 6:42-48.
24. Swaddiwudhipong W., Warintrawat S., Kunasol P., Sangwanloy O. Surveillance of neonatal tetanus in Thailand, 1977-1986. J Med Assoc Thai 1989, 72:638-642.
25. Andrews N. The value of linked data for research into surveillance and adverse events. Proceedings of the Public Health Information Development Unit Symposium on Health Data Linkage Proceedings. Sydney: Australian Government Department of Health and Ageing; 2003, p. 36-9. Available at: (accessed August 2010). http://www.publichealth.gov.au/pdf/reports_papers/symposium_procdngs_2003/andrews.pdf.